Nu Skin Enterprises, Inc. (NYSE:NUS) was the target of unusually large options trading activity on Monday. Traders bought 1,793 put options on the stock. This represents an increase of 936% compared to the typical volume of 173 put options.
Nu Skin Enterprises (NYSE NUS) traded down $1.09 during trading hours on Wednesday, reaching $73.24. 503,102 shares of the company’s stock traded hands, compared to its average volume of 490,046. The company has a quick ratio of 1.17, a current ratio of 1.74 and a debt-to-equity ratio of 0.44. The firm has a market cap of $3,860.00, a price-to-earnings ratio of 22.75, a price-to-earnings-growth ratio of 2.06 and a beta of 1.43. Nu Skin Enterprises has a 12 month low of $50.00 and a 12 month high of $75.00.
Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, February 15th. The company reported $1.20 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.01. The company had revenue of $666.20 million for the quarter, compared to analyst estimates of $667.39 million. Nu Skin Enterprises had a net margin of 5.68% and a return on equity of 25.23%. Nu Skin Enterprises’s revenue was up 25.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.79 EPS. sell-side analysts anticipate that Nu Skin Enterprises will post 3.56 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 14th. Stockholders of record on Monday, February 26th will be issued a $0.365 dividend. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.36. This represents a $1.46 annualized dividend and a dividend yield of 1.99%. The ex-dividend date of this dividend is Friday, February 23rd. Nu Skin Enterprises’s dividend payout ratio is currently 45.34%.
A number of analysts have recently commented on NUS shares. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Tuesday, November 14th. Deutsche Bank boosted their target price on shares of Nu Skin Enterprises from $75.00 to $77.00 and gave the stock a “buy” rating in a research note on Friday, February 16th. Pivotal Research reissued a “buy” rating and set a $90.00 target price on shares of Nu Skin Enterprises in a research note on Friday, February 16th. Citigroup restated a “buy” rating and set a $81.00 price target (up from $70.00) on shares of Nu Skin Enterprises in a research report on Tuesday, January 23rd. Finally, Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 price target on the stock in a research report on Saturday, December 30th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. The company has an average rating of “Hold” and an average target price of $71.29.
In other Nu Skin Enterprises news, Chairman Steven Lund sold 108,132 shares of Nu Skin Enterprises stock in a transaction on Friday, December 22nd. The shares were sold at an average price of $68.81, for a total value of $7,440,562.92. Following the completion of the transaction, the chairman now owns 4,769 shares of the company’s stock, valued at $328,154.89. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel D Matthew Dorny sold 3,000 shares of Nu Skin Enterprises stock in a transaction on Monday, March 5th. The shares were sold at an average price of $72.69, for a total transaction of $218,070.00. Following the completion of the transaction, the general counsel now directly owns 44,399 shares of the company’s stock, valued at approximately $3,227,363.31. The disclosure for this sale can be found here. Insiders have sold 214,702 shares of company stock valued at $14,863,554 over the last quarter. Insiders own 5.20% of the company’s stock.
Several hedge funds have recently modified their holdings of NUS. Old Mutual Global Investors UK Ltd. lifted its holdings in shares of Nu Skin Enterprises by 179,062.6% in the 3rd quarter. Old Mutual Global Investors UK Ltd. now owns 503,447 shares of the company’s stock worth $30,951,000 after acquiring an additional 503,166 shares during the last quarter. Skandinaviska Enskilda Banken AB publ lifted its holdings in shares of Nu Skin Enterprises by 462.8% in the 3rd quarter. Skandinaviska Enskilda Banken AB publ now owns 570,100 shares of the company’s stock worth $35,050,000 after acquiring an additional 468,800 shares during the last quarter. Prudential Financial Inc. lifted its holdings in shares of Nu Skin Enterprises by 826.4% in the 3rd quarter. Prudential Financial Inc. now owns 374,549 shares of the company’s stock worth $23,027,000 after acquiring an additional 334,120 shares during the last quarter. APG Asset Management N.V. lifted its holdings in shares of Nu Skin Enterprises by 159.2% in the 4th quarter. APG Asset Management N.V. now owns 402,500 shares of the company’s stock worth $22,870,000 after acquiring an additional 247,200 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new position in shares of Nu Skin Enterprises in the 4th quarter worth approximately $13,373,000. Hedge funds and other institutional investors own 76.62% of the company’s stock.
WARNING: “Traders Purchase Large Volume of Nu Skin Enterprises Put Options (NUS)” was originally published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://ledgergazette.com/2018/03/15/traders-purchase-high-volume-of-put-options-on-nu-skin-enterprises-nus.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.